Product InformationRegistration Status: Active
XERAVA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG PER VIAL is approved to be sold in Singapore with effective from 2020-04-15. It is marketed by EVEREST MEDICINES (SINGAPORE) PTE LTD, with the registration number of SIN15930P.
This product contains Eravacycline 50mg/vial in the form of INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. It is approved for INTRAVENOUS use.
This product is manufactured by Patheon Manufacturing Services LLC in UNITED STATES.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Eravacycline has been used in trials studying the treatment of End Stage Renal Disease, Impaired Hepatic Function, Complicated Intra-abdominal Infection, and Complicated Urinary Tract Infections (cUTI).
Eravacycline | Eravacycline |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.